ELIZABETH KELLEY

Mental DisabilitY BLOG.

  • HOME
  • BIO
  • BOOKS
  • FAQS
  • NEWSLETTERS & PRESS
  • MENTAL DISABILITY BLOG
  • FEDERAL PRACTICE
  • TESTIMONIALS
  • CONTACT

9/27/2019

Veteran’s Agency Approves Use of Costly Depression Drug

Read Now
 
Picture
​In the face of a rising rate of suicides among veterans, the Department of Veteran’s Affairs has decided to approve the use of a new, expensive drug to treat depression. This is despite concerns among doctors and other experts regarding the effectiveness of the drug. The drug is called Spravato and is manufactured by a division of Johnson & Johnson. The VA has approved the use of the drug, also known as esketamine, by doctors in its more than 1,000 clinics across the nation. 
 
Spravato
 
The Food and Drug Administration (FDA) approved the use of Spravato for severe depression in March of 2019. The drug represents a new direction in depression treatment. Spravato is a nasal spray derived from an anesthetic called ketamine. The drug is a departure from the usual antidepressants such as Prozac. 
 
The nasal spray contains esketamine, an active part of the ketamine molecule. It is recommended that it be taken twice a week for four weeks with later boosters as needed. The drug is usually taken in conjunction with more traditional antidepressants. People taking Spravato are monitored in the doctor’s office for two hours after taking the drug due to side effects such as hallucinations.
 
Issues With the Drug
 
Experts are not completely convinced of the effectiveness of Spravato in treating severe depression. The development of the drug came after a number of small studies found that generic ketamine provided fast relief to some severely depressed people who failed to respond to other treatments. Doctors believe that, since Spravato is different from generic ketamine, further trials and studies should be conducted.
 
Generic ketamine has been available for some time and is used by a number of doctors to treat severe depression. It is administered through a number of intravenous doses that cost about $400 per dose. Spravato, on the other hand, costs up to $7,000 for a course of treatment and additional clinic costs due to the monitoring that must take place. 
 
If you or a loved one has a mental disability and has been arrested or convicted of a crime, you need an experienced criminal defense attorney on your side. Elizabeth Kelley specializes in representing individuals with mental disabilities. To schedule a consultation call (509) 991-7058.

Share


Comments are closed.
Details

    Archives

    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019

    Categories

    All

    RSS Feed

East Coast 
​
Elizabeth Kelley, Attorney at Law
5 Columbus Circle, Ste. 710
New York, NY 10019
West Coast
Elizabeth Kelley, Attorney at Law
2525 E 29th Ave., Ste. 10-B #225
Spokane, WA 99223
phone: 509.991.7058
email: zealousadvocacy@aol.com
Nothing contained on this website is to be considered as the rendering of legal advice for specific cases, and readers are responsible for obtaining such advice from their own legal counsel.
  • HOME
  • BIO
  • BOOKS
  • FAQS
  • NEWSLETTERS & PRESS
  • MENTAL DISABILITY BLOG
  • FEDERAL PRACTICE
  • TESTIMONIALS
  • CONTACT